Atlas Trials

A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects

Clinical trial NCT03378635 · COMPLETED

Trial details

NCT number
NCT03378635
Sponsor
Zealand Pharma
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HypoglycemiaDiabetes Mellitus, Type 1
Start date
2017-12-07
Primary completion
2018-04-27
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.